Courts Revived Tylenol ADHD Lawsuits, But Science Still Shows No Link
Last updated:
When the news broke Monday that a federal appeals court had reinstated more than 500 lawsuits linking Tylenol use during pregnancy to autism and ADHD, the headlines read like a scientific verdict. Parents of children who struggle with attention started searching whether something they took during pregnancy had caused it. The answer from the research is not what the coverage implied.
The 2nd U.S. Circuit Court of Appeals in Manhattan ruled on July 13, 2026, that a lower court judge improperly excluded expert witnesses for the plaintiffs. That is a procedural decision about who gets to speak in court, not a finding about causation. Two weeks earlier, JAMA Internal Medicine published the most rigorous study ever conducted on this exact question: 708,020 mother-child pairs, sibling-matched to eliminate the genetic and environmental confounders that made earlier research unreliable. The result was unambiguous. No causal link between prenatal acetaminophen use and autism or ADHD.
TL;DR
The 2nd U.S. Circuit Court of Appeals on July 13, 2026, reinstated more than 500 lawsuits alleging prenatal Tylenol use caused autism and ADHD. The ruling was procedural: the lower court improperly excluded plaintiffs’ expert witnesses.
No court has concluded that acetaminophen causes autism or ADHD. The ruling concerns who gets to testify at trial, not what the evidence says about causation.
A JAMA Internal Medicine study published June 29, 2026, analyzed 708,020 mother-child pairs using a sibling-matched design. Prenatal acetaminophen exposure was not associated with autism (adjusted hazard ratio 1.00) or ADHD (adjusted hazard ratio 1.01).
Results held across all trimesters, all doses, and all usage patterns. Earlier positive associations in conventional studies were traced to familial confounding, not the drug.
The American College of Obstetricians and Gynecologists reaffirmed in September 2025 that acetaminophen is “well studied and proven to be safe for use in pregnancy.”
A federal appeals court on July 13, 2026, reinstated more than 500 lawsuits linking prenatal Tylenol use to autism and ADHD. Coverage treated it as a scientific story. Two weeks earlier, the most rigorous study ever conducted on this question found no causal link. Here is what the ruling actually decided, and what the science actually says.
Common questions
Does the appeals court ruling mean Tylenol causes ADHD or autism?
No. The 2nd Circuit’s ruling on July 13, 2026, was procedural: the lower court had improperly excluded expert witnesses hired by the plaintiffs. The appeals court sent the cases back for further proceedings. No court has concluded that acetaminophen causes autism or ADHD. A lawsuit reinstated is not a causation finding.
Is it safe to take Tylenol (acetaminophen) during pregnancy?
The American College of Obstetricians and Gynecologists reaffirmed in September 2025 that acetaminophen is “well studied and proven to be safe for use in pregnancy” and remains the recommended option for pain and fever management. A JAMA Internal Medicine study published June 29, 2026, using a sibling-matched design on 708,020 mother-child pairs, found no association with autism or ADHD across any trimester, dosage, or usage pattern. Discuss specific decisions with your provider. A screener or assessment for learning or attention differences is a starting point, not a diagnosis, and not a substitute for a professional clinical evaluation if your child needs formal accommodations or an IEP or 504 plan.
My child has ADHD or autism. Could prenatal Tylenol use have caused it?
The current best evidence says no. The sibling-matched JAMA Internal Medicine study published June 29, 2026, analyzed 708,020 mother-child pairs specifically to control for the familial factors that distorted earlier research. Prenatal acetaminophen exposure was not associated with ADHD (adjusted hazard ratio 1.01) or autism (adjusted hazard ratio 1.00). Earlier studies that showed a positive signal were traced to confounding from mothers’ underlying health conditions, not the drug itself. ADHD and autism have complex genetic and environmental roots. The current evidence base does not support prenatal acetaminophen as a cause.
What support options exist for children who struggle with attention and focus?
Attention, working memory, and processing speed are trainable cognitive skills that develop with the right kind of targeted practice. For children who need formal diagnosis and accommodations, a clinical ADHD evaluation is the required route to medication, IEP support, and a 504 plan. A multi-system assessment is a complementary tool that maps which specific processing skills your child needs to strengthen, giving families and schools a clearer picture of where to focus effort. It is a starting point, not a replacement for clinical evaluation when that is what your child needs.
The 2nd U.S. Circuit Court of Appeals on July 13 reinstated more than 500 private lawsuits against Kenvue, the maker of Tylenol (acetaminophen), after ruling that U.S. District Judge Denise Cote in Manhattan had improperly excluded testimony from three expert doctors hired by the plaintiffs. The plaintiffs argued that prenatal acetaminophen use caused autism and ADHD in their children. Judge Cote had dismissed the cases in December 2024, criticizing the methodology of the plaintiffs’ experts.
The appeals court reversed that exclusion ruling and sent the cases back to Judge Cote for further proceedings. The court concluded that the judge applied too strict a standard in deciding whether the experts were qualified to testify. No court has concluded that acetaminophen causes autism or ADHD. The ruling decides only whether certain witnesses will be permitted to speak at trial.
Author Quote"
I had herpes zoster during my pregnancy, yet I did not take paracetamol for myself at that time because of the concerns in the news. As a researcher and mother, I share the deep-seated concerns that many women face. Our study provides the reassurance I wish I had and would have helped me with the pain I was experiencing.
"
What the coverage gets wrong
Most news coverage of Monday’s 2nd Circuit ruling treats the reinstatement of 500+ lawsuits as evidence that the Tylenol-ADHD link is scientifically credible. It is not. The ruling decided whether the plaintiffs’ expert witnesses were improperly excluded from testifying, a question of procedural evidence law, not a review of the underlying science. Courts evaluate whether testimony meets admissibility standards; they do not conduct independent scientific reviews. The JAMA Internal Medicine study published two weeks earlier (708,020 mother-child pairs, sibling-matched) showed adjusted hazard ratios of 1.00 for autism and 1.01 for ADHD, the closest to zero association a study of this scale produces. A lawsuit reinstated means plaintiffs’ experts get a seat at trial. It means nothing about what the medication does.
What the science showed while courts debated
On June 29, 2026, JAMA Internal Medicine published a study designed specifically to solve the methodological problem that made earlier research unreliable. Researchers at the University of Hong Kong and Aston University analyzed 708,020 mother-child pairs across more than two decades of electronic health records, using a sibling-matched design: for each family where one child was exposed to acetaminophen in the womb and a sibling was not, the researchers compared outcomes between those two children from the same mother.
That design cancels out the confounders that distorted earlier studies. A mother who takes acetaminophen during pregnancy often takes it for a fever, an infection, or chronic pain. Those underlying conditions, not the medication, could independently shape a child’s development. Sibling-matching eliminates shared genetics, maternal health patterns, and household environment, isolating the drug as the only variable. The result: no association between prenatal acetaminophen exposure and autism (adjusted hazard ratio 1.00) or ADHD (adjusted hazard ratio 1.01), consistent across all trimesters, all dosage levels, and every usage pattern from sporadic to long-term. The positive associations in earlier conventional studies? Researchers traced those to residual familial confounding, not the medication.
The framing the health coverage missed is this: a federal court deciding whether expert witnesses meet admissibility standards is not evaluating the science those witnesses hold. It is deciding process. Meanwhile, the evidence base on the cognitive processing systems involved in ADHD now includes one of the largest and best-designed pregnancy cohort studies ever completed, showing no causal link. The American College of Obstetricians and Gynecologists reviewed the literature in September 2025 and reaffirmed that acetaminophen “is well studied and proven to be safe for use in pregnancy.”
Key Takeaways:
1
The ruling was procedural, not scientific: The 2nd Circuit reinstated 500+ Tylenol lawsuits after ruling a lower court wrongly excluded expert witnesses, a decision about trial process, not whether acetaminophen causes ADHD or autism.
2
The best available study showed no link: A JAMA Internal Medicine study published June 29, 2026, analyzed 708,020 mother-child pairs using a sibling-matched design and found no association between prenatal acetaminophen use and autism or ADHD across any trimester, dose, or usage pattern.
3
ACOG reaffirmed safety in September 2025: The American College of Obstetricians and Gynecologists reviewed current evidence and confirmed acetaminophen remains the recommended option for pain and fever during pregnancy, with no change to clinical guidance.
What this means if you are a parent right now
Two different parents are reading this story. One is pregnant and deciding whether to take Tylenol for a fever tonight. The answer from ACOG, the World Health Organization, and the current best evidence is the same: acetaminophen remains the first-choice option for pain and fever during pregnancy. Take it as needed, in moderation, in consultation with your provider. An untreated high fever during pregnancy carries its own documented risks to fetal development. The procedural ruling from Monday does not change that guidance.
The other parent is raising a child who struggles with attention or has an autism diagnosis, and is now wondering if something they took a decade ago caused it. The sibling-matched JAMA study addresses this directly. Prenatal acetaminophen use, across all dosages and all trimesters, was not associated with autism or ADHD in children. Lead researcher Dr. Shan Luo, who designed the study after experiencing this fear herself, explained what was at stake: “I had herpes zoster during my pregnancy, yet I did not take paracetamol for myself at that time because of the concerns in the news. As a researcher and mother, I share the deep-seated concerns that many women face. Our study provides the reassurance I wish I had and would have helped me with the pain I was experiencing.”
The brain your child has today is not fixed by anything that happened in utero. Neuroplasticity research, including studies from Yale and Stanford, shows that attention, focus, and processing skills develop with the right kind of targeted effort. The guilt you carry about what you took during pregnancy is far less useful to your child than understanding what support they need now, and what you as their parent have real leverage to build alongside them.
The villain in this story is not a company, a drug, or a court. It is a pattern in health coverage that treats legal proceedings as scientific verdicts, generating fear in parents who deserve clarity instead. When a court reinstates a lawsuit, it means plaintiffs get their day at trial, not that the lawsuit’s claims have been validated by evidence. These are not the same thing, and covering them as though they are leaves parents of children with attention challenges or autism carrying guilt that the best available science does not support.
Your child’s brain is not fixed by anything that happened in utero. Neuroplasticity research, including work from Yale and Stanford, shows that attention, focus, and processing skills develop with the right kind of targeted effort. The worry about what you took or didn’t take during pregnancy is far less useful to your child than understanding what support they need right now, and what you as their parent have real leverage to build. Our free Learning Difficulties Analysis maps the cognitive processing systems connected to attention, working memory, and focus, giving you a clearer picture of where your child needs support and where their strengths already are. It is a starting point, not a clinical diagnosis, and it does not replace a professional evaluation when formal accommodations are on the table.
Is Your Child Struggling in School?
Get Your FREE Personalized Learning Roadmap
Comprehensive assessment + instant access to research-backed strategies
Cancel anytime during your 7-day free trial—no risk.
References
Wan EYF, Chan EWY, Wong ICI, et al. — “Prenatal Acetaminophen (Paracetamol) Use and the Risk of Autism and/or ADHD Among Sibling-Matched Cohorts.” JAMA Internal Medicine, June 29, 2026. DOI: 10.1001/jamainternmed.2026.2215. Full text
2nd U.S. Circuit Court of Appeals (Manhattan), July 13, 2026 — ruling reinstating private lawsuits against Kenvue (In re: Acetaminophen ASD-ADHD Products Liability Litigation). Reported by Reuters, CNBC, The Hill, and US News.
ACOG Practice Advisory — “Acetaminophen Use in Pregnancy and Neurodevelopmental Outcomes.” September 2025. acog.org
